APA (7th ed.) Citation

T, I., MP, S., C, K., RS, K., J, C., NH, H., . . . E, D. (2026). Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT-An International, Randomized, Phase III, Noninferiority Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 44(7), 534. https://doi.org/10.1200/JCO-25-00621

Chicago Style (17th ed.) Citation

T, Iveson, et al. "Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT-An International, Randomized, Phase III, Noninferiority Trial." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 44, no. 7 (2026): 534. https://doi.org/10.1200/JCO-25-00621.

MLA (9th ed.) Citation

T, Iveson, et al. "Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT-An International, Randomized, Phase III, Noninferiority Trial." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 44, no. 7, 2026, p. 534, https://doi.org/10.1200/JCO-25-00621.